Ohio Gov. Mike DeWine stopped by Cincinnati Children’s on Dec. 5 to announce a major boost for pediatric cancer research—a $1.48 million grant to power the ENGRAFT learning network. This collaborative effort brings together experts, families, and partners to transform outcomes for kids needing stem cell transplants, as part of a $5 million statewide investment in fighting childhood cancer.
Discover how Cincinnati Children’s uses 3D imaging to improve precision and outcomes in pediatric physeal bar excision surgery.
The new Applied Gene and Cell Therapy Center will expand capacity for manufacturing viral vectors and cell-based products under Current Good Manufacturing Practice conditions, supporting complex trials in oncology, hematology and rare genetic disorders, with capabilities for large-scale bioreactor production and post-approval therapy manufacturing.
Discover how Cincinnati Children’s CF WELL program is transforming care for children with cystic fibrosis—addressing educational and mental health needs alongside clinical advances.
Researchers have achieved a breakthrough in kidney organoid development by creating early-stage plumbing that connects nephrons to waste-carrying tubules.
A Phase II clinical trial conducted in Ghana suggests that hydroxyurea — already a treatment offered for the most common form of sickle cell disease — also shows benefits for those with the hemoglobin SC (HbSC) variant of the condition.
Cincinnati Children’s is advancing catheter ablation techniques to treat arrhythmias in patients with congenital heart disease.
Discover how Cincinnati Children’s is accelerating research and clinical trials to advance therapies for myeloid malignancies across all age groups.
Cincinnati Children’s explores AI-powered Flight Plans to enhance decision-making and outcomes in pediatric heart care through data-driven, cloud-based tools.
Scientists are advancing lung research using AI and computational genomics to decode biology’s multidimensional complexity.